TBX3, the gene mutated in ulnar-mammary syndrome, promotes growth of mammary epithelial cells via repression of p19ARF, independently of p53.

Dulbecco Telethon Institute/CNR-ITB, Via F lli Cervi 93 Segrate, Milano, Italy.
Cell and Tissue Research (Impact Factor: 3.33). 06/2007; 328(2):301-16. DOI: 10.1007/s00441-006-0364-4
Source: PubMed

ABSTRACT TBX3, the gene mutated in ulnar-mammary syndrome (UMS), is involved in the production of a transcription factor of the T-box family, known to inhibit transcription from the p14ARF (p19ARF in mouse) promoter in fibroblasts and to contribute to cell immortalization. One of the main features of the UMS phenotype is the severe hypoplasia of the breast, associated with haploinsufficiency of the TBX3 gene product. In mice homozygous for the targeted disruption of Tbx3, the mammary glands (MGs) are nearly absent from early stages of embryogenesis, whereas in heterozygous adults, the MGs show reduced ductal branching. All these data strongly suggest a specific role of TBX3 in promoting the growth of mammary epithelial cells (MECs), although direct evidence of this is lacking. Here, we provide data showing the growth-promoting function of Tbx3 in several models of MECs, in association with its ability to repress the ARF promoter. However, no effect of Tbx3 on cell differentiation or apoptosis has been observed. The growth promoting function also entails the down-regulation of p21 ( CIP1/WAF ) and an increase in cyclin D1 but is independent of p53 and Mdm2 cell-cycle regulatory proteins, as p53-null MECs show similar growth responses associated with the up- or down-regulation of Tbx3. This is the first direct evidence that the level of Tbx3 expression positively controls the proliferation of MECs via pathways alternative to Mdm2-p53.

Download full-text


Available from: Gloria Bertoli, Apr 02, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The murine mammary system is a complex milieu of epithelial cell types that function together to support lactogenesis. The breast tissue is spatially and temporally regulated, with most growth occurring postnatally. The mature mammary gland displays two characteristic architectural features: ducts and terminal end buds. There are different cell types found in these two features that perform independent functions in the mature organ. In general, the mature gland is a bilayer system with a single layer of fibroblast-like myoepithelial cells encompassing an inner luminal epithelial layer. Upon pregnancy, the induction of alveolar secretory cells is initiated, which eventually leads to milk production. Milk is then channeled through the entire system via contraction of the myoepithelium, and eventually dispersed through the nipple. The mouse mammary gland is capable of multiple stages of development: growth, lactation and involution. These stages are regulated by cytokines and hormones depending on the developmental stage of the mouse and the physiological context (i.e. estrus). Numerous studies have shown the mammary epithelium is capable of regeneration upon transplantation. Recent reports have isolated fractions of cells enriched for duct forming ability and self-renewal. In addition, a distinct progenitor population was also identified that lacked the ability to form ducts in vivo but retained bipotentiality in vitro. This thesis builds on previous marker studies of mammary epithelial cells, using existing phenotypes to further enrich the mammary stem cell population. My data shows Thy-1, or CD90, is differentially expressed in mammary cells. In addition, Thy-1+CD24medCD49fhi cells are enriched for in vivo engraftment of ductal epithelium. These cells are approximately 10-fold enriched for duct-forming ability.. Importantly, the Thy-1+CD24medCD49hi phenotype enriched for cells that are capable of self-renewal and retain the full differentiation potential of the parent stem cells.. This data provided a new phenotype for the stem cells (MaSC). The Thy-1-CD24medCD49hi cells are not only diminished for engraftment but have significantly decreased self-renewal, suggesting they are a potential multipotent progenitor population. I have named them mammary multipotent progenitors, or MMPPs. A novel protein staining methodology revealed the Thy-1+CD24medCD49hi and Thy-1-CD24medCD49hi cells have keratin profile similar to myoepithelial cells Ph.D. Cellular & Molecular Biology University of Michigan, Horace H. Rackham School of Graduate Studies
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent researches have discovered that MDM2 ( murine double minute 2, or HDM2 for the human congener) protein is the main negative regulator of p53, which is an attractive therapeutic target in oncology because its tumor-suppressor activity which can be stimulated to eradicate tumor cells. Inhibiting the p53-MDM2 interaction is a promising approach for activating p53, because this association is well characterized at the structural and biological levels. A number of drug screening approaches and technologies have been used to identity novel inhibitors of the p53-MDM2 interaction. This review will detail the development history of MDM2 protein and the p53-MDM2 interaction, the major classes of novel small-molecular p53-MDM2 binding inhibitors, key medicinal action with the protein-protein interaction and in vitro or in vivo biological activtiies.
    Current Medicinal Chemistry 07/2008; 15(17):1720-1730. DOI:10.2174/092986708784872375 · 3.85 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Since its isolation in a behavioral screen in 1971, work on the gene, optomotor-blind (omb, FlyBase: bifid, bi), has proceeded in many laboratories. The Drosophila T-box transcription factor, Omb, is active in several developmental processes, in particular in those of wing, eye, and abdominal tergites and optic lobes. The orthologous genes, TBX2 and TBX3, are found overexpressed or amplified in an increasing number of human cancers, emphasizing the importance of Tbx genes also in postdevelopmental processes. This review summarizes recent findings pertaining to omb and orthologous genes.
    Journal of neurogenetics 01/2009; 23(1-2):15-33. DOI:10.1080/01677060802471619 · 1.38 Impact Factor